Karim, M Y <br/><br/>
Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents.  [electronic resource] 

 -  Rheumatology (Oxford, England)  Aug 2002 
 - 876-82 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1462-0324 
<br/><br/><label>Standard No.: </label>10.1093/rheumatology/41.8.876  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Antinuclear--blood<br/>Azathioprine--therapeutic use<br/>Cyclophosphamide--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Lupus Erythematosus, Systemic--blood<br/>Male<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Mycophenolic Acid--analogs & derivatives<br/>Proteinuria--prevention & control<br/>Racial Groups<br/>Statistics, Nonparametric<br/>Time Factors<br/>Treatment Failure